International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries

BACKGROUND: Continuous androgen deprivation therapy (CADT) is commonly used for patients with non-metastatic prostate cancer as primary therapy for high-risk disease, adjuvant therapy together with radiation or for recurrence after initial local therapy. Intermittent ADT (IADT), a recently developed...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:ESMO Open
Glavni autori: Liede, Alexander, Hallett, David C, Hope, Kirsty, Graham, Alex, Arellano, Jorge, Shahinian, Vahakn B
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2016
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070274/
https://ncbi.nlm.nih.gov/pubmed/27843596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000040
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items